Autophagy regulates differentiation of ovarian granulosa cells through degradation of WT1

• Published in: Autophagy Vol. 18; no. 8; pp. 1864 - 1878
• Main Authors: Shao, Tong, Ke, Hanni, Liu, Ran, Xu, Lan, Han, Shuang, Zhang, Xiruo, Dang, Yujie, Jiao, Xue, Li, Wei, Chen, Zi-Jiang, Qin, Yingying, Zhao, Shidou
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 03.08.2022
• Subjects: Autophagy; differentiation; granulosa cells; premature ovarian insufficiency; Research Paper; WT1; differentiation; granulosa cells; premature ovarian insufficiency; WT1; Autophagy
• ISSN: 1554-8627; 1554-8635
• DOI: 10.1080/15548627.2021.2005415

Ovarian granulosa cells (GCs) proliferate and differentiate along with follicular growth, and this is indispensable for oocyte development and female fertility. Although the role of macroautophagy/autophagy in ovarian function has been reported, its contribution to the regulation of GC characteristics remains elusive. The siRNA-mediated knockdown of two key autophagy-related genes ATG5 and BECN1 and the autophagy inhibitor chloroquine were used to interfere with autophagy in GCs. Inhibition of autophagy both genetically and pharmacologically resulted in decreased expression of genes associated with GC differentiation, including CYP19A1/Aromatase and FSHR, as well as in reduced estradiol synthesis. Mechanistically, when autophagy was disrupted, the transcription factor WT1 accumulated in GCs due to its insufficient degradation by the autophagic pathway, and this inhibited GC differentiation. Finally, decreased expression of several autophagy-related genes, as well as reduced LC3-II:LC3-I and elevated SQSTM1/p62 protein levels, which are indications of decreased autophagy, were detected in GCs from biochemical premature ovarian insufficiency patients. In summary, our study reveals that autophagy regulates the differentiation of ovarian GCs by degrading WT1 and that insufficient autophagy might be involved in ovarian dysfunction. Abbreviations: ATG: autophagy related; bPOI: biochemical premature ovarian insufficiency; CHX: cycloheximide; Co-IP: co-immunoprecipitation; CQ: chloroquine; E 2 : estradiol; FSH: follicle stimulating hormone; FSHR: follicle stimulating hormone receptor; GC: granulosa cell; LIR: LC3-interacting region; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; POI: premature ovarian insufficiency; RAP: rapamycin; siRNA: small interfering RNA; WT1: WT1 transcription factor